ArticleDrug safety2025

A Longitudinal Post-authorization Safety Study of Golimumab in Treatment of Ulcerative Colitis: A Cohort Study in Denmark and Sweden, 2013-2021.

Annette Kjær Ersbøll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.